FRANKLIN LAKES, N.J., Aug. 13, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the launch of BD Sterifill Advance™, a new prefillable polymer syringe specially engineered to deliver large volume injectable drugs by way of intravenous infusion.
BD Sterifill Advance™ is a 50 mL plastic prefillable syringe made with a highly advanced cyclic olefin polymer that is designed to offer a number of advantages to drug manufacturers and healthcare professionals including reduced breakage, glass-like transparency, and low levels of extractables. This unique polymer combined with a specific coating technology provides smooth gliding, ensuring an accurate and consistent infusion rate.
"BD applied our extensive knowledge and experience with prefillable syringes to design this new syringe with properties that support the delivery of large volume injectable drugs, making the advantages of this option more widely available," said Claude Dartiguelongue, President, BD Medical - Pharmaceutical Systems. "We are offering drug developers, healthcare workers and patients a new option for prefill drug delivery that sets new standards in both safety and convenience."
The BD Sterifill Advance™ Plastic Prefillable Syringe aims to provide a seamless transition for healthcare workers in the hospital setting because the syringe was developed from the design of BD Plastipak™, a leading disposable syringe. This unique design avoids any syringe pump reprogramming activity for hospitals and aims to reduce risks of administration errors for healthcare workers. In addition, the syringe has been designed to be highly durable, reducing the probability of flange breakage and ensures a reliable connection with syringe pumps.The syringe can address a number of drug delivery needs for the intravenous infusion of large volumes of drugs including: anesthesia, pain management, cardiac therapy and nutrition amongst others. The product can also be used in a variety of settings for parenteral administration of pharmaceutical compounds.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts